What are the side effects of lorazepam (Ativan) and how can they be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lorazepam Side Effects and Management

Lorazepam has significant side effects including respiratory depression, hypotension, sedation, dizziness, weakness, unsteadiness, memory impairment, confusion, physical dependence, and withdrawal reactions, which should be carefully monitored and managed to reduce morbidity and mortality. 1, 2

Common Side Effects

Lorazepam, a benzodiazepine medication, is associated with several common side effects:

  • Sedation and drowsiness - most frequent side effect 1
  • Dizziness and unsteadiness - increasing fall risk 1
  • Weakness - affecting daily functioning 1
  • Cognitive effects - memory impairment and confusion 3
  • Respiratory depression - especially when combined with other CNS depressants 2
  • Hypotension - can be clinically significant 2

Serious Side Effects

Respiratory and Cardiovascular Effects

  • Respiratory depression - particularly concerning when administered with other cardiopulmonary depressants like opioids 2
  • Systemic hypotension - more likely in patients with baseline cardiovascular instability 2
  • Cardiopulmonary instability - higher risk in patients with baseline respiratory insufficiency 2

Propylene Glycol Toxicity

  • Parenteral formulations contain propylene glycol which can cause:
    • Metabolic acidosis
    • Acute kidney injury
  • Total daily IV doses as low as 1 mg/kg can cause propylene glycol toxicity 2
  • Monitoring via serum osmol gap (>10-12 mOsm/L indicates significant accumulation) 2

Dependence and Withdrawal

  • Physical dependence develops with continued use 1
  • Withdrawal reactions can be severe if stopped suddenly, including:
    • Seizures
    • Severe mental/nervous system changes
    • Depression
    • Hallucinations
    • Increased activity/talking
    • Loss of touch with reality
    • Suicidal thoughts/actions 1
  • Rebound phenomena after withdrawal:
    • Rebound insomnia - can be several times worse than baseline sleep disturbance 3
    • Rebound anxiety - significant increases in tension and anxiety 4

Special Population Considerations

Elderly Patients

  • Increased sensitivity to sedative effects 2
  • Decreased clearance - benzodiazepine clearance decreases with age 2
  • Higher risk of cognitive impairment and falls 5

Patients with Organ Dysfunction

  • Hepatic dysfunction - reduced clearance as all benzodiazepines are metabolized by the liver 2
  • Renal failure - increased elimination half-life and prolonged clinical effect 2

Drug Interactions

  • Opioids - increased risk of severe drowsiness, respiratory depression, coma, and death 1
  • Alcohol and other CNS depressants - enhanced sedative effects 1
  • Medications affecting cytochrome P450 - can reduce benzodiazepine clearance 2

Management of Side Effects

Prevention Strategies

  1. Appropriate patient selection:

    • Avoid in patients with severe respiratory insufficiency
    • Use with caution in elderly patients and those with hepatic/renal dysfunction 2
  2. Dosing considerations:

    • Start with lowest effective dose
    • Use for shortest duration possible (not recommended for longer than 4 months) 1
    • Avoid abrupt discontinuation 1
  3. Monitoring:

    • Regular assessment of respiratory status and blood pressure
    • Monitor for signs of propylene glycol toxicity with IV administration 2
    • Watch for cognitive effects and functional impairment 3

Managing Specific Side Effects

Sedation/Cognitive Effects

  • Reduce dose if excessive sedation occurs
  • Avoid activities requiring mental alertness until effects are known 1
  • Consider daytime dosing adjustments to minimize impact on daily functioning

Respiratory Depression

  • Ensure availability of resuscitation equipment when administering IV
  • Consider oxygen supplementation in high-risk patients 2

Propylene Glycol Toxicity

  • Monitor serum osmol gap in patients receiving high-dose IV lorazepam
  • Consider alternative benzodiazepines if prolonged IV therapy is needed 2

Dependence and Withdrawal

  • Gradual tapering when discontinuing to prevent withdrawal symptoms 1
  • Taper schedule should be individualized based on dose and duration of treatment
  • Monitor closely for withdrawal symptoms during tapering

Alternatives to Consider

When lorazepam side effects are problematic, consider:

  • Non-pharmacological interventions for anxiety and agitation (should be first-line) 5
  • Alternative benzodiazepines with different pharmacokinetic profiles based on patient characteristics 6
  • Non-benzodiazepine anxiolytics for patients at high risk of respiratory depression or dependence

Important Pitfalls to Avoid

  • Using benzodiazepines as first-line therapy for agitation in elderly or cognitively impaired patients 5
  • Combining with other CNS depressants without appropriate dose adjustments 1
  • Prolonged use leading to tolerance and dependence 2
  • Abrupt discontinuation after regular use 1
  • Overlooking propylene glycol toxicity in critically ill patients receiving IV lorazepam 2

By understanding these side effects and implementing appropriate monitoring and management strategies, the risks associated with lorazepam therapy can be minimized while maintaining therapeutic efficacy.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lorazepam-efficacy, side effects, and rebound phenomena.

Clinical pharmacology and therapeutics, 1982

Guideline

Managing Agitation and Confusion in Patients with Cognitive Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Surge of Midazolam Use in the Midst of Lorazepam Shortage.

Journal of clinical psychopharmacology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.